Clinical Trials
43 trialsA Phase Ib/II Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
Guangzhou Lupeng Pharmaceutical Company LTD.
HEMO-CONNECT
Centre Hospitalier de la côte Basque
CUREMZL002
Institute of Hematology & Blood Diseases Hospital, China
BAF_FRontier-1
Eli Lilly and Company
Family-Focused Study to Support Medication for Opioid Use Disorder
University of Wisconsin, Madison
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma
Sinocelltech Ltd.
Clinical Trial of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
Shanghai Zhongshan Hospital
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
Incyte Corporation
CUREFL03
Institute of Hematology & Blood Diseases Hospital, China
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic Impairment
MindRank AI Ltd
FLOURISH
Sun Yat-sen University
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
New York State Psychiatric Institute
ZR2 Versus R2 Regimen in the Treatment of Newly Diagnosed Follicular Lymphoma
Henan Cancer Hospital
ETCABIO
University Hospital, Angers
Transpulmonary Pressure-guided Mechanical Ventilation Strategy in Right Ventricular Protection in Patients With ARDS
Beijing Chao Yang Hospital
Archonc-001
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
Ascentage Pharma Group Inc.
RSWITCH
International Food Policy Research Institute
ACITAC-001
Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS
MENTOR
Center for Health Sciences, Serbia
IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
PPPOCUS
University of California, Irvine
TC011_FL_201
TICAROS Co., Ltd.
ENARCT-ARDS
Nanfang Hospital, Southern Medical University
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
Case Comprehensive Cancer Center
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Alliance for Clinical Trials in Oncology
Transcatheter Edge-to-Edge Repair In Moderate and Exertional-Induced Severe MR (TIMER)
Sun Yat-sen University
CLEAR
Universität Münster
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
Tel-Aviv Sourasky Medical Center
Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in the Treatment of Recurrent/Refractory Follicular Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
First Affiliated Hospital Xi'an Jiaotong University
Implementation and Evaluation of an Internet-Based Stress Management Program for Health Students in the Sfax Region
University of Sfax
A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FL
Tianjin Medical University Cancer Institute and Hospital
JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma
Peking University Cancer Hospital & Institute
DENUTADOM
Centre hospitalier Henri Mondor d'Aurillac
Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular Lymphoma
Zhejiang Cancer Hospital
Developing a Nonpharmacological Pain Intervention for Community-dwelling Older Adults With Dementia
Drexel University
Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma
Sun Yat-sen University
Zanubrutinib, Obinutuzumab and Lenalidomide (ZGR) in High-risk Treatment-naive Patients with Follicular Lymphoma (FL)
Ruijin Hospital
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer
Peking University People's Hospital
A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma
Jiangsu HengRui Medicine Co., Ltd.
Oncoquest-L Vaccine in Patients With Previously Untreated Stage III or IV, Asymptomatic, Non-bulky Follicular Lymphoma
XEME Biopharma Inc.